I can’t reliably answer “biotech news today” without knowing which geography, sub-sector, or companies you care about, because “biotech” spans pharma, therapeutics, diagnostics, biotech stocks, FDA/EMA actions, mergers, and patents.
What kind of biotech news do you want?
- US biotech (FDA, NIH, SEC, big trials)
- EU/UK (EMA, NICE, MHRA)
- Clinical trials (phase 1–3 readouts, approvals, holds)
- M&A and funding (deals, IPOs, venture financing)
- Biotech stocks/earnings (market-moving updates)
- Patents and exclusivity (who’s suing whom; approval timelines)
If you tell me (1) your region and (2) 3–5 companies or topics (e.g., “cancer drugs,” “gene therapy,” “GLP-1 competitors,” “immuno-oncology”), I’ll produce a tight roundup of the most relevant items.